Cardiovascular Research Advance Access first published online on July 25, 2009
This version [Corrected Proof] published online on August 11, 2009
Cardiovascular Research, doi:10.1093/cvr/cvp255
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stressing the ubiquitin/proteasome system
Department of Cell and Molecular Biology, Karolinska Institutet, von Eulers väg 3 S-17177, Stockholm, Sweden
* Corresponding author. Tel: +46 852487384, Fax: +46 8313529, Email: nico.dantuma{at}ki.se (N.P.D.); kristina.lindsten{at}ki.se (K.L.)
Unfolded and misfolded proteins are inherently toxic to cells and have to be quickly and efficiently eliminated before they intoxicate the intracellular environment. This is of particular importance during proteotoxic stress when, as a consequence of intrinsic or extrinsic factors, the levels of misfolded proteins are transiently or persistently elevated. To meet this demand, metazoan cells have developed specific protein quality control mechanisms that allow the identification and proper handling of non-native proteins. An important defence mechanism is the specific destruction of these proteins by the ubiquitin/proteasome system (UPS). A number of studies have shown that various proteotoxic stress conditions can cause functional impairment of the UPS resulting in cellular dysfunction and apoptosis. In this review, we will summarize our current understanding of proteotoxic stress-induced dysfunction of the UPS and some of its implications for human pathologies.
KEYWORDS Ubiquitin; Proteasome; Proteotoxic stress; Conformational diseases; Ubiquitylation; Deubiquitylation
Time for primary review: 12 days
This article is part of the Spotlight Issue on: The Role of the Ubiquitin–Proteasome Pathway in Cardiovascular Disease
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Depre, S. R. Powell, and X. Wang The role of the ubiquitin-proteasome pathway in cardiovascular disease Cardiovasc Res, January 15, 2010; 85(2): 251 - 252. [Full Text] [PDF] |
||||
